BamSEC and AlphaSense Join Forces
Learn More

Pelthos Therapeutics Inc. – Material Contracts

NYSE American: PTHS    
Share price (11/17/26): $6.84    
Market cap (11/17/26): $26.9 million

Material Contracts Filter

EX-10.15
from 10-Q 12 pages Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q 8 pages Pelthos Therapeutics Inc. 2026 Equity Incentive Plan Performance Stock Unit Agreement
12/34/56
EX-10.4
from 10-Q 9 pages Pelthos Therapeutics Inc. 2026 Equity Incentive Plan Restricted Stock Unit Agreement
12/34/56
EX-10.3
from 10-Q 8 pages Pelthos Therapeutics Inc. 2026 Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Pelthos Therapeutics Inc. 2023 Equity Incentive Plan Performance Stock Unit Agreement
12/34/56
EX-10.8
from 425 5 pages Second Amendment to Executive Employment Agreement
12/34/56
EX-10.8
from 8-K 5 pages Second Amendment to Executive Employment Agreement
12/34/56
EX-10.7
from 8-K 8 pages Pelthos Therapeutics Inc. First Amendment and Waiver to Senior Secured Convertible Notes
12/34/56
EX-10.7
from 425 8 pages Pelthos Therapeutics Inc. First Amendment and Waiver to Senior Secured Convertible Notes
12/34/56
EX-10.5
from 425 38 pages Form of Registration Rights Agreement
12/34/56
EX-10.5
from 8-K 38 pages Form of Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 6 pages Form of Lock-Up Agreement
12/34/56
EX-10.4
from 425 6 pages Form of Lock-Up Agreement
12/34/56
EX-10.3
from 425 8 pages Lock-Up Agreement
12/34/56
EX-10.3
from 8-K 8 pages Lock-Up Agreement
12/34/56
EX-10.2
from 8-K 15 pages Castle Creek Biosciences, Inc. Support Agreement
12/34/56
EX-10.2
from 425 15 pages Castle Creek Biosciences, Inc. Support Agreement
12/34/56
EX-10.1
from 425 55 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 55 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 16 pages Pelthos Therapeutics Inc. 2026 Equity Incentive Plan
12/34/56